Optibrium is dedicated to providing software to guide decisions involving complex, uncertain data in an intuitive way. Our primary product, StarDrop, is focussed on the drug discovery industry, helping scientists to guide decisions in the design and selection of potential drug molecules.
Optibrium was founded in 2009 as a spin-out of BioFocus DPI (formerly Inpharmatica). The founding group was responsible for the development of StarDrop from 2003 and, prior to this, research and development of related technologies since 1994.
Based in Cambridge, UK, Optibrium has a global customer base ranging from top-10 pharmaceutical companies to small biotechs and academic groups.
Products StarDrop
Software
Contact Optibrium Ltd
Request further information.
Note: Your message will be sent directly to the supplier
New Derek™ module for StarDrop™ facilitates the efficient design and selection of safe, efficacious compounds in early drug discovery
Optibrium and Lhasa Limited, providers of software for compound design, selection and property prediction,today announce a technology collaboration agreement. Lhasa’s Derek Nexus™ platform for knowledge-based prediction of compound toxicity will be integratedas an optional plug-in module for Optibrium’s StarDrop software, that guides the design and selection of high quality compounds in drug discovery...
Optibrium extends StarDrop’s capabilities to guide the design of high quality compound libraries for drug discovery
Optibrium™, developer of software solutions for drug discovery, today announces a new version of its StarDrop platform. Version 5.3 introduces new features focused on the design of virtual libraries, guided by StarDrop’s unique multi-parameter optimisation capabilities to prioritise compounds with the best balance of properties for synthesis and testing...
Enter the StarDrop application note competition to be in with a chance
Optibrium, developer of software solutions for drug discovery, today announces the launch of its application note competition offering StarDrop users the opportunity to win a trip to the American Chemical Society (ACS) Spring National Meeting & Exposition 2013 in New Orleans, Louisiana. For a chance to win, StarDrop users who use the software in their drug discovery projects are invited to submit an application note demonstrating their innovative use of StarDrop.
Optibrium, developer of software solutions for drug discovery, today announces a new version of its StarDropTM platform. StarDrop 5.2 features a new plug-in module that provides users with access to Cresset's FieldAlignTM technology, which offers a unique, 3-dimensional insight into the biological activity of their compounds. This new development is the first result of the technology exchange between Optibrium and Cresset announced earlier this year, and adds another powerful tool to StarDrop that will enable chemists to understand the 3D structure activity relationship (SAR) of their chemistry in order to optimise their compounds...
Innovative software and services provider Cresset, and Optibrium, a provider of software solutions for drug discovery, today announce an agreement to collaborate on the development of next-generation platforms. The innovative companies will work together, combining unique approaches to help drug discovery projects quickly identify novel, potent compounds with a high chance of success downstream...
Optibrium, a provider of software solutions for drug discovery, today launches StarDrop 5.1, an upgraded version of its innovative support tool which helps drug discovery scientists to guide key decisions in drug discovery and quickly achieve successful project outcomes. As a result of this upgrade, StarDrop's unique capabilities to guide the design and selection of high quality, novel compounds are now available on the Apple Mac, a reflection of the increasing popularity of Macs within the industry...
Optibrium, a provider of software solutions for drug discovery, announces the availability of a range of models to help predict the toxicity of potential new compounds. Optibrium has generated a range of Quantitative Structure Activity Relationship (QSAR) models of key toxicity endpoints, based on data made available by the US Environmental Protection Agency (EPA) as part of its Toxicity Evaluation Software Toolkit (T.E.S.T.). The toxicity prediction models were built with the Auto-Modeller module of the newly launched StarDrop 5 and are available to all StarDrop users free-of-charge...
Optibrium, a provider of software solutions for drug discovery, will be officially launching the next generation of StarDrop featuring the ground-breaking Nova module on booth #1121 at the American Chemical Society (ACS) National Exposition, 27-31 March, 2011, Anaheim, CA. This intuitive platform helps to guide scientists' decisions to quickly identify compounds with a high chance of success for their drug discovery project...
Optibrium, a provider of software solutions for drug discovery, and Tessella, the information technology and consulting services company and world leaders in digital preservation technology, today published a new paper highlighting that scientists' instincts may not always lead them to making good drug discovery decisions.
Optibrium, a provider of software solutions for drug discovery, today celebrates two significant milestones: its first year of trading and signing its 25th customer. Based in Cambridge, UK, Optibrium has a global customer base ranging from top-ten pharma companies to small biotechs and academic groups, including Johnson & Johnson PR&D, Pfizer, Merck Serono, Teijin Pharma Ltd., Galapagos N.V., MRC Technology, The Campbell Family Institute for Breast Cancer Research and The University of Dundee.
Optibrium, a provider of software solutions for drug discovery, will be showcasing StarVueTM on booth #121 at 2010 Spring ACS National Meeting and Exposition, March 21-25, San Francisco, CA, USA.
Optibrium and Lhasa Limited, providers of software for compound design, selection and property prediction,today announce a technology collaboration agreement. Lhasa’s Derek Nexus™ platform for knowledge-based prediction of compound toxicity will be integratedas an optional plug-in module for Optibrium’s StarDrop software, that guides the design and selection of high quality compounds in drug discovery...
Optibrium™, developer of software solutions for drug discovery, today announces a new version of its StarDrop platform. Version 5.3 introduces new features focused on the design of virtual libraries, guided by StarDrop’s unique multi-parameter optimisation capabilities to prioritise compounds with the best balance of properties for synthesis and testing...
Optibrium, developer of software solutions for drug discovery, today announces the launch of its application note competition offering StarDrop users the opportunity to win a trip to the American Chemical Society (ACS) Spring National Meeting & Exposition 2013 in New Orleans, Louisiana. For a chance to win, StarDrop users who use the software in their drug discovery projects are invited to submit an application note demonstrating their innovative use of StarDrop.
Innovative software and services provider Cresset, and Optibrium, a provider of software solutions for drug discovery, today announce an agreement to collaborate on the development of next-generation platforms. The innovative companies will work together, combining unique approaches to help drug discovery projects quickly identify novel, potent compounds with a high chance of success downstream...
Optibrium, a provider of software solutions for drug discovery, today launches StarDrop 5.1, an upgraded version of its innovative support tool which helps drug discovery scientists to guide key decisions in drug discovery and quickly achieve successful project outcomes. As a result of this upgrade, StarDrop's unique capabilities to guide the design and selection of high quality, novel compounds are now available on the Apple Mac, a reflection of the increasing popularity of Macs within the industry...
Optibrium, a provider of software solutions for drug discovery, announces the availability of a range of models to help predict the toxicity of potential new compounds. Optibrium has generated a range of Quantitative Structure Activity Relationship (QSAR) models of key toxicity endpoints, based on data made available by the US Environmental Protection Agency (EPA) as part of its Toxicity Evaluation Software Toolkit (T.E.S.T.). The toxicity prediction models were built with the Auto-Modeller module of the newly launched StarDrop 5 and are available to all StarDrop users free-of-charge...